Sharifi-Rad, Javad

Link to this page

Authority KeyName Variants
orcid::0000-0002-7301-8151
  • Sharifi-Rad, Javad (3)
Projects

Author's Bibliography

Natural products and synthetic analogues against HIV: A perspective to develop new potential anti-HIV drugs

Popović-Djordjević, Jelena; Quispe, Cristina; Giordo, Roberta; Kostić, Aleksandar; Katanić Stanković, Jelena S.; Tsouh Fokoue, Patrick Valere; Carbone, Katya; Martorell, Miquel; Kumar, Manoj; Pintus, Gianfranco; Sharifi-Rad, Javad; Docea, Anca Oana; Calina, Daniela

(Elsevier Masson s.r.l., 2022)

TY  - JOUR
AU  - Popović-Djordjević, Jelena
AU  - Quispe, Cristina
AU  - Giordo, Roberta
AU  - Kostić, Aleksandar
AU  - Katanić Stanković, Jelena S.
AU  - Tsouh Fokoue, Patrick Valere
AU  - Carbone, Katya
AU  - Martorell, Miquel
AU  - Kumar, Manoj
AU  - Pintus, Gianfranco
AU  - Sharifi-Rad, Javad
AU  - Docea, Anca Oana
AU  - Calina, Daniela
PY  - 2022
UR  - http://aspace.agrif.bg.ac.rs/handle/123456789/6044
AB  - The human immunodeficiency virus (HIV) is responsible for acquired immune deficiency syndrome (AIDS), one of the major pandemic diseases. Highly active antiretroviral therapy (HAART) is the standard HIV-treatment regimen that usually comprises a combination of three or more antiretroviral drugs. HIV reverse transcriptase inhibitors are the main HAART target, which involves the use of both nucleoside reverse transcriptase inhibitors (NRTIs) and non-nucleoside reverse transcriptase inhibitors (NNRTIs). However, compounds affecting other aspects of HIV replication, such as virus entry and fusion or important viral enzymes, such as integrases and proteases, have also been developed. Natural compounds from different sources, like plants, microbial and marine organisms, showed promising anti-HIV activities to the point of establishing the basis for developing new drugs. Indeed, natural compounds-based therapies have the potential to become more efficient than conventional HAART, with less or no side effects. This review aims to gather and discuss the current information about the anti-HIV activity of natural and synthetic compounds, their history and mechanism of action as well as the role of plants and their bioactive compounds as a source of new anti-HIV drugs.
PB  - Elsevier Masson s.r.l.
T2  - European Journal of Medicinal Chemistry
T1  - Natural products and synthetic analogues against HIV: A perspective to develop new potential anti-HIV drugs
SP  - 114217
VL  - 233
DO  - 10.1016/j.ejmech.2022.114217
ER  - 
@article{
author = "Popović-Djordjević, Jelena and Quispe, Cristina and Giordo, Roberta and Kostić, Aleksandar and Katanić Stanković, Jelena S. and Tsouh Fokoue, Patrick Valere and Carbone, Katya and Martorell, Miquel and Kumar, Manoj and Pintus, Gianfranco and Sharifi-Rad, Javad and Docea, Anca Oana and Calina, Daniela",
year = "2022",
abstract = "The human immunodeficiency virus (HIV) is responsible for acquired immune deficiency syndrome (AIDS), one of the major pandemic diseases. Highly active antiretroviral therapy (HAART) is the standard HIV-treatment regimen that usually comprises a combination of three or more antiretroviral drugs. HIV reverse transcriptase inhibitors are the main HAART target, which involves the use of both nucleoside reverse transcriptase inhibitors (NRTIs) and non-nucleoside reverse transcriptase inhibitors (NNRTIs). However, compounds affecting other aspects of HIV replication, such as virus entry and fusion or important viral enzymes, such as integrases and proteases, have also been developed. Natural compounds from different sources, like plants, microbial and marine organisms, showed promising anti-HIV activities to the point of establishing the basis for developing new drugs. Indeed, natural compounds-based therapies have the potential to become more efficient than conventional HAART, with less or no side effects. This review aims to gather and discuss the current information about the anti-HIV activity of natural and synthetic compounds, their history and mechanism of action as well as the role of plants and their bioactive compounds as a source of new anti-HIV drugs.",
publisher = "Elsevier Masson s.r.l.",
journal = "European Journal of Medicinal Chemistry",
title = "Natural products and synthetic analogues against HIV: A perspective to develop new potential anti-HIV drugs",
pages = "114217",
volume = "233",
doi = "10.1016/j.ejmech.2022.114217"
}
Popović-Djordjević, J., Quispe, C., Giordo, R., Kostić, A., Katanić Stanković, J. S., Tsouh Fokoue, P. V., Carbone, K., Martorell, M., Kumar, M., Pintus, G., Sharifi-Rad, J., Docea, A. O.,& Calina, D.. (2022). Natural products and synthetic analogues against HIV: A perspective to develop new potential anti-HIV drugs. in European Journal of Medicinal Chemistry
Elsevier Masson s.r.l.., 233, 114217.
https://doi.org/10.1016/j.ejmech.2022.114217
Popović-Djordjević J, Quispe C, Giordo R, Kostić A, Katanić Stanković JS, Tsouh Fokoue PV, Carbone K, Martorell M, Kumar M, Pintus G, Sharifi-Rad J, Docea AO, Calina D. Natural products and synthetic analogues against HIV: A perspective to develop new potential anti-HIV drugs. in European Journal of Medicinal Chemistry. 2022;233:114217.
doi:10.1016/j.ejmech.2022.114217 .
Popović-Djordjević, Jelena, Quispe, Cristina, Giordo, Roberta, Kostić, Aleksandar, Katanić Stanković, Jelena S., Tsouh Fokoue, Patrick Valere, Carbone, Katya, Martorell, Miquel, Kumar, Manoj, Pintus, Gianfranco, Sharifi-Rad, Javad, Docea, Anca Oana, Calina, Daniela, "Natural products and synthetic analogues against HIV: A perspective to develop new potential anti-HIV drugs" in European Journal of Medicinal Chemistry, 233 (2022):114217,
https://doi.org/10.1016/j.ejmech.2022.114217 . .
29
29

Convolvulus plant-A comprehensive review from phytochemical composition to pharmacy

Salehi, Bahare; Krochmal-Marczak, Barbara; Skiba, Dominika; Patra, Jayanta Kumar; Das, Swagat Kumar; Das, Gitishree; Popović-Djordjević, Jelena; Kostić, Aleksandar; Kumar, Nanjangud V.Anil; Tripathi, Ayushi; Al-Snafi, Ali Esmail; Arserim-Ucar, Dilhun Keriman; Konovalov, Dmitry Alekseevich; Csupor, Dezso; Shukla, Ila; Azmi, Lubna; Mishra, Abhay Prakash; Sharifi-Rad, Javad; Sawicka, Barbara; Martins, Natalia; Taheri, Yasaman; Fokou, Patrick Valere Tsouh; Capasso, Raffaele; Martorell, Miquel

(Wiley, Hoboken, 2020)

TY  - JOUR
AU  - Salehi, Bahare
AU  - Krochmal-Marczak, Barbara
AU  - Skiba, Dominika
AU  - Patra, Jayanta Kumar
AU  - Das, Swagat Kumar
AU  - Das, Gitishree
AU  - Popović-Djordjević, Jelena
AU  - Kostić, Aleksandar
AU  - Kumar, Nanjangud V.Anil
AU  - Tripathi, Ayushi
AU  - Al-Snafi, Ali Esmail
AU  - Arserim-Ucar, Dilhun Keriman
AU  - Konovalov, Dmitry Alekseevich
AU  - Csupor, Dezso
AU  - Shukla, Ila
AU  - Azmi, Lubna
AU  - Mishra, Abhay Prakash
AU  - Sharifi-Rad, Javad
AU  - Sawicka, Barbara
AU  - Martins, Natalia
AU  - Taheri, Yasaman
AU  - Fokou, Patrick Valere Tsouh
AU  - Capasso, Raffaele
AU  - Martorell, Miquel
PY  - 2020
UR  - http://aspace.agrif.bg.ac.rs/handle/123456789/5355
AB  - Convolvulus genus is a representative of the family of Convolvulaceae. Convolvulus plants are broadly distributed all over the world and has been used for many centuries as herbal medicine. Convolvulus genus contains various phytochemicals such as flavonoids, alkaloids, carbohydrates, phenolic compounds, mucilage, unsaturated sterols or terpenes, resin, tannins, lactones, and proteins. This review highlights the phytochemical composition, antimicrobial and antioxidant activities, application as food preservative, traditional medicine use, anticancer activities, and clinical effectiveness in human of Convolvulus plants. All the parts of Convolvulus plants possess therapeutic benefits; preliminary pharmacological data validated their use in traditional medicine. However, further preclinical and clinical experiments are warranted before any application in human health.
PB  - Wiley, Hoboken
T2  - Phytotherapy Research
T1  - Convolvulus plant-A comprehensive review from phytochemical composition to pharmacy
EP  - 328
IS  - 2
SP  - 315
VL  - 34
DO  - 10.1002/ptr.6540
ER  - 
@article{
author = "Salehi, Bahare and Krochmal-Marczak, Barbara and Skiba, Dominika and Patra, Jayanta Kumar and Das, Swagat Kumar and Das, Gitishree and Popović-Djordjević, Jelena and Kostić, Aleksandar and Kumar, Nanjangud V.Anil and Tripathi, Ayushi and Al-Snafi, Ali Esmail and Arserim-Ucar, Dilhun Keriman and Konovalov, Dmitry Alekseevich and Csupor, Dezso and Shukla, Ila and Azmi, Lubna and Mishra, Abhay Prakash and Sharifi-Rad, Javad and Sawicka, Barbara and Martins, Natalia and Taheri, Yasaman and Fokou, Patrick Valere Tsouh and Capasso, Raffaele and Martorell, Miquel",
year = "2020",
abstract = "Convolvulus genus is a representative of the family of Convolvulaceae. Convolvulus plants are broadly distributed all over the world and has been used for many centuries as herbal medicine. Convolvulus genus contains various phytochemicals such as flavonoids, alkaloids, carbohydrates, phenolic compounds, mucilage, unsaturated sterols or terpenes, resin, tannins, lactones, and proteins. This review highlights the phytochemical composition, antimicrobial and antioxidant activities, application as food preservative, traditional medicine use, anticancer activities, and clinical effectiveness in human of Convolvulus plants. All the parts of Convolvulus plants possess therapeutic benefits; preliminary pharmacological data validated their use in traditional medicine. However, further preclinical and clinical experiments are warranted before any application in human health.",
publisher = "Wiley, Hoboken",
journal = "Phytotherapy Research",
title = "Convolvulus plant-A comprehensive review from phytochemical composition to pharmacy",
pages = "328-315",
number = "2",
volume = "34",
doi = "10.1002/ptr.6540"
}
Salehi, B., Krochmal-Marczak, B., Skiba, D., Patra, J. K., Das, S. K., Das, G., Popović-Djordjević, J., Kostić, A., Kumar, N. V.Anil, Tripathi, A., Al-Snafi, A. E., Arserim-Ucar, D. K., Konovalov, D. A., Csupor, D., Shukla, I., Azmi, L., Mishra, A. P., Sharifi-Rad, J., Sawicka, B., Martins, N., Taheri, Y., Fokou, P. V. T., Capasso, R.,& Martorell, M.. (2020). Convolvulus plant-A comprehensive review from phytochemical composition to pharmacy. in Phytotherapy Research
Wiley, Hoboken., 34(2), 315-328.
https://doi.org/10.1002/ptr.6540
Salehi B, Krochmal-Marczak B, Skiba D, Patra JK, Das SK, Das G, Popović-Djordjević J, Kostić A, Kumar NV, Tripathi A, Al-Snafi AE, Arserim-Ucar DK, Konovalov DA, Csupor D, Shukla I, Azmi L, Mishra AP, Sharifi-Rad J, Sawicka B, Martins N, Taheri Y, Fokou PVT, Capasso R, Martorell M. Convolvulus plant-A comprehensive review from phytochemical composition to pharmacy. in Phytotherapy Research. 2020;34(2):315-328.
doi:10.1002/ptr.6540 .
Salehi, Bahare, Krochmal-Marczak, Barbara, Skiba, Dominika, Patra, Jayanta Kumar, Das, Swagat Kumar, Das, Gitishree, Popović-Djordjević, Jelena, Kostić, Aleksandar, Kumar, Nanjangud V.Anil, Tripathi, Ayushi, Al-Snafi, Ali Esmail, Arserim-Ucar, Dilhun Keriman, Konovalov, Dmitry Alekseevich, Csupor, Dezso, Shukla, Ila, Azmi, Lubna, Mishra, Abhay Prakash, Sharifi-Rad, Javad, Sawicka, Barbara, Martins, Natalia, Taheri, Yasaman, Fokou, Patrick Valere Tsouh, Capasso, Raffaele, Martorell, Miquel, "Convolvulus plant-A comprehensive review from phytochemical composition to pharmacy" in Phytotherapy Research, 34, no. 2 (2020):315-328,
https://doi.org/10.1002/ptr.6540 . .
1
37
12
35

Prosopis Plant Chemical Composition and Pharmacological Attributes: Targeting Clinical Studies from Preclinical Evidence

Sharifi-Rad, Javad; Kobarfard, Farzad; Ata, Athar; Ayatollahi, Seyed Abdulmajid; Khosravi-Dehaghi, Nafiseh; Jugran, Arun Kumar; Tomas, Merve; Capanoglu, Esra; Matthews, Karl R.; Popović-Djordjević, Jelena; Kostić, Aleksandar; Kamiloglu, Senem; Sharopov, Farukh; Choudhary, Muhammad Iqbal; Martins, Natalia

(MDPI, BASEL, 2019)

TY  - JOUR
AU  - Sharifi-Rad, Javad
AU  - Kobarfard, Farzad
AU  - Ata, Athar
AU  - Ayatollahi, Seyed Abdulmajid
AU  - Khosravi-Dehaghi, Nafiseh
AU  - Jugran, Arun Kumar
AU  - Tomas, Merve
AU  - Capanoglu, Esra
AU  - Matthews, Karl R.
AU  - Popović-Djordjević, Jelena
AU  - Kostić, Aleksandar
AU  - Kamiloglu, Senem
AU  - Sharopov, Farukh
AU  - Choudhary, Muhammad Iqbal
AU  - Martins, Natalia
PY  - 2019
UR  - http://aspace.agrif.bg.ac.rs/handle/123456789/4978
AB  - Members of the Prosopis genus are native to America, Africa and Asia, and have long been used in traditional medicine. The Prosopis species most commonly used for medicinal purposes are P. africana, P. alba, P. cineraria, P. farcta, P. glandulosa, P. juliflora, P. nigra, P. ruscifolia and P. spicigera, which are highly effective in asthma, birth/postpartum pains, callouses, conjunctivitis, diabetes, diarrhea, expectorant, fever, flu, lactation, liver infection, malaria, otitis, pains, pediculosis, rheumatism, scabies, skin inflammations, spasm, stomach ache, bladder and pancreas stone removal. Flour, syrup, and beverages from Prosopis pods have also been potentially used for foods and food supplement formulation in many regions of the world. In addition, various in vitro and in vivo studies have revealed interesting antiplasmodial, antipyretic, anti-inflammatory, antimicrobial, anticancer, antidiabetic and wound healing effects. The phytochemical composition of Prosopis plants, namely their content of C-glycosyl flavones (such as schaftoside, isoschaftoside, vicenin II, vitexin and isovitexin) has been increasingly correlated with the observed biological effects. Thus, given the literature reports, Prosopis plants have positive impact on the human diet and general health. In this sense, the present review provides an in-depth overview of the literature data regarding Prosopis plants' chemical composition, pharmacological and food applications, covering from pre-clinical data to upcoming clinical studies.
PB  - MDPI, BASEL
T2  - Biomolecules
T1  - Prosopis Plant Chemical Composition and Pharmacological Attributes: Targeting Clinical Studies from Preclinical Evidence
IS  - 12
VL  - 9
DO  - 10.3390/biom9120777
ER  - 
@article{
author = "Sharifi-Rad, Javad and Kobarfard, Farzad and Ata, Athar and Ayatollahi, Seyed Abdulmajid and Khosravi-Dehaghi, Nafiseh and Jugran, Arun Kumar and Tomas, Merve and Capanoglu, Esra and Matthews, Karl R. and Popović-Djordjević, Jelena and Kostić, Aleksandar and Kamiloglu, Senem and Sharopov, Farukh and Choudhary, Muhammad Iqbal and Martins, Natalia",
year = "2019",
abstract = "Members of the Prosopis genus are native to America, Africa and Asia, and have long been used in traditional medicine. The Prosopis species most commonly used for medicinal purposes are P. africana, P. alba, P. cineraria, P. farcta, P. glandulosa, P. juliflora, P. nigra, P. ruscifolia and P. spicigera, which are highly effective in asthma, birth/postpartum pains, callouses, conjunctivitis, diabetes, diarrhea, expectorant, fever, flu, lactation, liver infection, malaria, otitis, pains, pediculosis, rheumatism, scabies, skin inflammations, spasm, stomach ache, bladder and pancreas stone removal. Flour, syrup, and beverages from Prosopis pods have also been potentially used for foods and food supplement formulation in many regions of the world. In addition, various in vitro and in vivo studies have revealed interesting antiplasmodial, antipyretic, anti-inflammatory, antimicrobial, anticancer, antidiabetic and wound healing effects. The phytochemical composition of Prosopis plants, namely their content of C-glycosyl flavones (such as schaftoside, isoschaftoside, vicenin II, vitexin and isovitexin) has been increasingly correlated with the observed biological effects. Thus, given the literature reports, Prosopis plants have positive impact on the human diet and general health. In this sense, the present review provides an in-depth overview of the literature data regarding Prosopis plants' chemical composition, pharmacological and food applications, covering from pre-clinical data to upcoming clinical studies.",
publisher = "MDPI, BASEL",
journal = "Biomolecules",
title = "Prosopis Plant Chemical Composition and Pharmacological Attributes: Targeting Clinical Studies from Preclinical Evidence",
number = "12",
volume = "9",
doi = "10.3390/biom9120777"
}
Sharifi-Rad, J., Kobarfard, F., Ata, A., Ayatollahi, S. A., Khosravi-Dehaghi, N., Jugran, A. K., Tomas, M., Capanoglu, E., Matthews, K. R., Popović-Djordjević, J., Kostić, A., Kamiloglu, S., Sharopov, F., Choudhary, M. I.,& Martins, N.. (2019). Prosopis Plant Chemical Composition and Pharmacological Attributes: Targeting Clinical Studies from Preclinical Evidence. in Biomolecules
MDPI, BASEL., 9(12).
https://doi.org/10.3390/biom9120777
Sharifi-Rad J, Kobarfard F, Ata A, Ayatollahi SA, Khosravi-Dehaghi N, Jugran AK, Tomas M, Capanoglu E, Matthews KR, Popović-Djordjević J, Kostić A, Kamiloglu S, Sharopov F, Choudhary MI, Martins N. Prosopis Plant Chemical Composition and Pharmacological Attributes: Targeting Clinical Studies from Preclinical Evidence. in Biomolecules. 2019;9(12).
doi:10.3390/biom9120777 .
Sharifi-Rad, Javad, Kobarfard, Farzad, Ata, Athar, Ayatollahi, Seyed Abdulmajid, Khosravi-Dehaghi, Nafiseh, Jugran, Arun Kumar, Tomas, Merve, Capanoglu, Esra, Matthews, Karl R., Popović-Djordjević, Jelena, Kostić, Aleksandar, Kamiloglu, Senem, Sharopov, Farukh, Choudhary, Muhammad Iqbal, Martins, Natalia, "Prosopis Plant Chemical Composition and Pharmacological Attributes: Targeting Clinical Studies from Preclinical Evidence" in Biomolecules, 9, no. 12 (2019),
https://doi.org/10.3390/biom9120777 . .
29
10
33